TRA-418, a novel compound having both thromboxane A(2) receptor antagonistic and prostaglandin I(2) receptor agonistic activities: its antiplatelet effects in human and animal platelets.
about
Prostacyclin: an inflammatory paradox.Thromboxane A2 receptor: biology and function of a peculiar receptor that remains resistant for therapeutic targeting.Effects of TRA-418, a novel TP-receptor antagonist, and IP-receptor agonist, on human platelet activation and aggregation.Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor.The specific thromboxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies.
P2860
TRA-418, a novel compound having both thromboxane A(2) receptor antagonistic and prostaglandin I(2) receptor agonistic activities: its antiplatelet effects in human and animal platelets.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
TRA-418, a novel compound havi ...... in human and animal platelets.
@en
TRA-418, a novel compound havi ...... in human and animal platelets.
@nl
type
label
TRA-418, a novel compound havi ...... in human and animal platelets.
@en
TRA-418, a novel compound havi ...... in human and animal platelets.
@nl
prefLabel
TRA-418, a novel compound havi ...... in human and animal platelets.
@en
TRA-418, a novel compound havi ...... in human and animal platelets.
@nl
P2093
P1476
TRA-418, a novel compound havi ...... in human and animal platelets.
@en
P2093
Miyamoto M
P2860
P304
P356
10.1046/J.1538-7836.2003.00257.X
P577
2003-08-01T00:00:00Z